Bambusa Therapeutics, Inc. Common Stock

BBTX

Market cap $801M

15.73 USD

-0.12

0.76%

At close Updated Nov 6, 4:00 PM EST

1 day

-0.76%

5 days

4.94%

1 month

4.94%

3 months

4.94%

6 months

4.94%

Year to date

4.94%

1 year

4.94%

5 years

4.94%

10 years

4.94%

About: Bambusa Therapeutics Inc is a clinical-stage biotechnology company developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases.

Healthcare Biotechnology

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Neutral

Seeking Alpha

8 days ago

U.S. IPO Weekly Recap: Anthropic Files For Potentially Record-Breaking IPO

Three IPOs, one direct listing, and two SPACs priced during a challenging week for growth stocks. Just one SPAC is currently scheduled to list in the week ahead, although some smaller deals may also join the calendar throughout the week. Street research is expected for two companies in the week ahead, and six lock-up periods will be expiring.

See News Rankings

Price charts implemented using Lightweight Charts™

Bambusa Therapeutics, Inc. Common Stock BBTX Market cap $801M

News

Bambusa Therapeutics, Inc. Common Stock

BBTX

Market cap $801M